Clearpath Miniprep Colonoscopy Study

NCT ID: NCT01374945

Last Updated: 2013-02-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Use of Clearpath to facilitate successful completion of colonoscopy procedures with sub-optimal preparation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colonoscopy

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SOC preparation and colonoscopy

Group Type NO_INTERVENTION

No interventions assigned to this group

Miniprep and Clearpath

Group Type EXPERIMENTAL

Clearpath Lower GI

Intervention Type DEVICE

Clearpath device for cleaning of colon by irrigation and evacuation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Clearpath Lower GI

Clearpath device for cleaning of colon by irrigation and evacuation

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patient 18-70 years
2. Scheduled for colonoscopy
3. Providing informed consent

Exclusion Criteria

1. Known large polyps (\> 2 cm) for polypectomy
2. Inflammatory Bowel Disease (IBD)
3. Previous colonic surgery
4. Known or suspected stricture
5. Significant co morbidity
6. Significant diverticular disease
7. Contraindicated to receive oral Sodium Picosulfate solution
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

EasyGlide

INDUSTRY

Sponsor Role lead

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EasyGlide-CL-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.